Fig. 3
From: L-arginine dependence of breast cancer – molecular subtypes matter.
Kaplan-Meier survival analyses for total mortality in breast cancer patients. (a) Total mortality in patients with breast cancer (total cohort) with high or low ADMA plasma concentration; (b) total mortality in patients with Luminal A breast cancer with high or low ADMA plasma concentration; (c) total mortality in patients with breast cancer (total cohort) with high or low L-citrulline plasma concentration; (d) total mortality in patients with triple-negative breast cancer with high or low L-citrulline plasma concentration